Mcneil AB

🇸🇪Sweden

Country: 🇸🇪Sweden

Ownership: Subsidiary

Established: 1914-01-01

Employees: 501

Market Cap: -

Website: http://www.mcneilab.se

Clinical Trials

A Study of Butamirate Citrate Syrup Versus (vs) Sinecod Syrup (Vanilla) in Adult Healthy Study Volunteers

Phase 1

Withdrawn

Conditions: Healthy

Interventions: Drug: Butamirate citrate
Drug: Sinecod

First Posted Date: 2022-01-10

Last Posted Date: 2022-05-20

Lead Sponsor: McNeil AB

Registration Number: NCT05182047

Locations: 🇷🇺
"Scientific and Research centre Eco-safety" Limited Liability Company, 65, Yuri Gagarin prospect, Saint -Petersburg, Russian Federation

A Study of Combination Caplet With Loperamide Hydrochloride and Simethicone, and Imodium Express Tablets-lyophilizate Coadministered With Espumisan Capsule in Healthy Volunteers

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Combination Caplet with Loperamide HCl and Simethicone
Drug: Loperamide HCl
Drug: Simethicone

First Posted Date: 2019-12-05

Last Posted Date: 2020-09-10

Lead Sponsor: McNeil AB

Target Recruit Count: 48

Registration Number: NCT04186936

Locations: 🇷🇺
"Scientific and Research centre Eco-safety" Limited Liability Company, Saint-Petersburg, Russian Federation

A Study to Assess Bioquivalence Between a Novel Naproxen Sodium 275 mg Film-coated Tablet and Nalgesin Naproxen Sodium 275 mg Film-coated Tablet in Healthy Adult Volunteers

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Naproxen sodium (test product)
Drug: Naproxen sodium (reference product)

First Posted Date: 2018-10-05

Last Posted Date: 2020-01-23

Lead Sponsor: McNeil AB

Target Recruit Count: 28

Registration Number: NCT03697889

Locations: 🇷🇺
LLC "Scientific and Research centre Eco-safety", St.Petersburg, Russian Federation

A Study to Compare Two Formulations of Xylometazoline/Dexpanthenol Nasal Spray for the Treatment of Nasal Congestion.

Phase 3

Completed

Conditions: Nasal Congestion

Interventions: Drug: xylo+dex nasal spray (0.1 mg+5 mg/dose)
Drug: Nasic

First Posted Date: 2018-02-20

Last Posted Date: 2018-10-18

Lead Sponsor: McNeil AB

Target Recruit Count: 140

Registration Number: NCT03439436

Locations: 🇷🇺
"Scientific and Research centre Eco-safety" Limited Liability Company, St Petersburg, Russian Federation
🇷🇺
First Moscow State Medical University n. a. I. M. Sechenov, Moscow, Russian Federation
🇷🇺
Railways clinical hospital n.a.Semashko at Lublino station JSC "RZD", Moscow, Russian Federation

and more 2 locations

A Study to Determine the Efficacy and Safety of a Benzocaine Lozenge for Treatment of Sore Throat.

Phase 3

Completed

Conditions: Sore Throat

Interventions: Drug: Placebo
Drug: Benzocaine 8 mg

First Posted Date: 2018-02-14

Last Posted Date: 2018-10-18

Lead Sponsor: McNeil AB

Target Recruit Count: 260

Registration Number: NCT03432923

Locations: 🇷🇺
Railway Clinical Hospital n.a. N.A. Semashko Lyublino railway station of the Russian Railways, Stavropolskaya str., 23, build.1,, Moscow, Russian Federation
🇷🇺
Central Clinical Hospital of Russian Academy of Sciences Litovskiy bulvar, 1A, Moscow, Russian Federation
🇷🇺
Federal State Budgetary Institution "Policlinic #5" of Administrative Department of the President of the Russian Federation Plyushchikha str., 14, Moscow, Russian Federation

and more 16 locations

Clinical Study to Assess Bioequivalence Between Nicorette Extra Mint Gum and Nicorette® Mint Gum in Healthy Smokers

Phase 1

Completed

Conditions: Tobacco Dependence

Interventions: Drug: Nicorette Extra Mint 2 mg Gum
Drug: Nicorette Mint 2 mg Gum
Drug: Nicorette Extra Mint 4mg Gum
Drug: Nicorette Mint 4 mg Gum

First Posted Date: 2017-08-23

Last Posted Date: 2019-01-03

Lead Sponsor: McNeil AB

Target Recruit Count: 76

Registration Number: NCT03259607

Locations: 🇨🇳
Beijing Hospital, No.1, Beijing, China

A Bioequivalence Study Between Two Nicotine Replacement Therapies in Adult Healthy Smokers Motivated to Quit.

Phase 1

Completed

Conditions: Tobacco Dependence

Interventions: Drug: Nicorette Strongmint lozenge 4 mg
Drug: Niquitin MiniMint lozenge 4 mg

First Posted Date: 2017-04-26

Last Posted Date: 2018-07-27

Lead Sponsor: McNeil AB

Target Recruit Count: 244

Registration Number: NCT03130179

Locations: 🇷🇺
"Scientific and Clinical Center of JSC "RZD", Moscow, Russian Federation

Study to Test the Blood to See if a New Medicine is Likely to Provide Pain Relief Similar to a Product Already Sold in Stores

Phase 1

Completed

Conditions: Pain

Interventions: Drug: Ibuprofen

First Posted Date: 2012-03-15

Last Posted Date: 2012-07-10

Lead Sponsor: McNeil AB

Target Recruit Count: 32

Registration Number: NCT01555476

Locations: 🇸🇪
McNeil AB Clinical Pharmacology R&D, Lund, Sweden

A Study of an Experimental Nasal Spray in Subjects With Early Signs of the Common Cold

Not Applicable

Completed

Conditions: Common Cold

Interventions: Device: Polymeric Nasal Spray
Device: Sham Nasal Spray

First Posted Date: 2011-12-08

Last Posted Date: 2012-05-09

Lead Sponsor: McNeil AB

Target Recruit Count: 163

Registration Number: NCT01488604

Locations: 🇬🇧
Common Cold Center and Healthcare Clinical Trials, Cardiff, Wales, United Kingdom
🇬🇧
Synexus Thames Valley, Reading, Berkshire, United Kingdom
🇬🇧
Synexus Wales, Cardiff, Llaishen, United Kingdom

An Exploratory Study Comparing Two Nicotine Inhalers

Early Phase 1

Completed

Conditions: Tobacco Dependence

Interventions: Drug: Nicotine

First Posted Date: 2011-11-23

Last Posted Date: 2012-07-10

Lead Sponsor: McNeil AB

Target Recruit Count: 36

Registration Number: NCT01478230

Locations: 🇸🇪
McNeil AB Clinical Pharmacology R&D, Lund, Sweden

Home Terms & Conditions Privacy Policy